NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Sernova Corp (V: SVA)
SVA Technical Analysis
3
As on 1st Jun 2022 SVA STOCK Price closed @ 1.57 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.33 & Buy for SHORT-TERM with Stoploss of 1.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SVASTOCK Price
Open | 1.51 | Change | Price | % |
High | 1.57 | 1 Day | 0.09 | 6.08 |
Low | 1.46 | 1 Week | 0.05 | 3.29 |
Close | 1.57 | 1 Month | 0.12 | 8.28 |
Volume | 121400 | 1 Year | 1.16 | 282.93 |
52 Week High 2.42 | 52 Week Low 0.39 |
V Canada Most Active Stocks
SML | 1442.34 | % |
LUCK | 80.00 | % |
NU | 14.45 | % |
AEC | 0.14 | % |
VMC | 0.06 | % |
HELI | 0.04 | % |
ECR | 0.10 | % |
SCZ | 0.41 | % |
GSVR | 0.26 | % |
BRC | 0.51 | % |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
SVA Daily Charts |
SVA Intraday Charts |
Whats New @ Bazaartrend |
SVA Free Analysis |
|
SVA Important Levels Intraday
RESISTANCE | 1.78 |
RESISTANCE | 1.71 |
RESISTANCE | 1.67 |
RESISTANCE | 1.63 |
SUPPORT | 1.51 |
SUPPORT | 1.47 |
SUPPORT | 1.43 |
SUPPORT | 1.36 |
SVA Forecast October 2024
4th UP Forecast | 6.06 |
3rd UP Forecast | 4.62 |
2nd UP Forecast | 3.73 |
1st UP Forecast | 2.84 |
1st DOWN Forecast | 0.3 |
2nd DOWN Forecast | -0.59 |
3rd DOWN Forecast | -1.48 |
4th DOWN Forecast | -2.92 |
SVA Weekly Forecast
4th UP Forecast | 2.26 |
3rd UP Forecast | 2.04 |
2nd UP Forecast | 1.90 |
1st UP Forecast | 1.77 |
1st DOWN Forecast | 1.37 |
2nd DOWN Forecast | 1.24 |
3rd DOWN Forecast | 1.10 |
4th DOWN Forecast | 0.88 |
SVA Forecast2024
4th UP Forecast | 6.37 |
3rd UP Forecast | 4.83 |
2nd UP Forecast | 3.88 |
1st UP Forecast | 2.93 |
1st DOWN Forecast | 0.21 |
2nd DOWN Forecast | -0.74 |
3rd DOWN Forecast | -1.69 |
4th DOWN Forecast | -3.23 |
Sernova Corp ( V Canada Symbol : SVA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SVA Other Details
Segment | EQ | |
Market Capital | 330946752.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
SVA Address
SVA Latest News
SVA Business Profile
Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada. Address: The Stiller Centre, London, ON, Canada, N6G 4X8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service